AzTrials
AzTrials

Primary GlaucomaNCT06071494

The Effect Of Tropical Fruits In Patients With Primary Glaucoma

A study testing Tropical fruits in people with Primary Glaucoma, run by Universiti Sains Malaysia at 1 site in Malaysia.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

To evaluate the effect of regular tropical fruits intake in primary glaucoma patients. Methodology : Research Design Randomized controlled trial Study Duration February 2024-June 2025 Study Location 1. Read more about this study

Who is it for?
Ages 40 years and older
Conditions the study is for
Primary Glaucoma
What is being tested?
Tropical fruits
Could I receive a placebo?
No, everyone receives an active treatment
How many people
104 participants
Where
1 siteMalaysia
Study dates
1 Feb 2024to 1 May 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 40 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Patient with confirmed diagnosis of POAG and PACG
  • Patient on medical treatment and achieved target IOP in last 6 months
  • Good compliance with pressure lowering agents

Who cannot join

  • Poorly controlled diabetes mellitus, hypertension and hyperlipidaemia
  • Active smoker
  • Mentally challenge based on diagnosis
  • History of previous intraocular surgery other than uncomplicated cataract surgery within past 6 months
  • Poor signal strength OCT RNFL
  • Patient with media opacities that affect the reliability of OCT measurements , such as Cornea opacity, dense cataract with LOCS III of more than grade 2, vitreous haemorrhage
  • Other optic neuropathy apart from glaucoma
  • History of taking antioxidant supplement 3 months prior to recruitment

Trial locations and contacts

1 site in 1 country.

Malaysia1 site
  • Univerisiti Sains Malaysia

    Kubang Kerian, Kota Bharu, 16150

Other trials in Malaysia

About this study

Official title: A Randomized Controlled Trial Of The Effect Of Tropical Fruits On Intraocular Pressure And Retinal Nerve Fibre Layer Thickness In Patients With Primary Glaucoma

To evaluate the effect of regular tropical fruits intake in primary glaucoma patients.

Methodology :

Research Design Randomized controlled trial

Study Duration February 2024-June 2025

Study Location

  1. Ophthalmology Clinic, Hospital Universiti Sains Malaysia, Kelantan

Source Reference Population Adults with primary glaucoma in Peninsular Malaysia

Study Source Population Adults with primary glaucoma attending Ophthalmology clinic, Hospital Universiti Sains Malaysia during study duration.

Read the detailed description

General objective To evaluate the effect of regular tropical fruits intake on intra-ocular pressure (IOP) and retinal nerve fibre layer thickness (RNFL) in primary glaucoma patients.

Research hypothesis

  1. There is a significant different in the IOP measurement between those whose taking regular tropical fruits and not taking them at baseline, 1 month, 3 month and 6 month among patients with primary glaucoma.
  2. There is a significant different in RNFL thickness between those whose taking regular tropical fruits and not taking them at baseline, 1 month, 3 month and 6 month among patients with primary glaucoma.

Inclusion Criteria

  1. Patient with confirmed diagnosis of POAG and PACG
  2. Patient on medical treatment and achieved target IOP in last 6 months
  3. Good compliance with pressure lowering agents

Exclusion Criteria

  1. Poorly controlled diabetes mellitus, hypertension and hyperlipidaemia
  2. Active smoker
  3. Mentally challenge based on diagnosis
  4. History of previous intraocular surgery other than uncomplicated cataract surgery within past 6 months
  5. Poor signal strength OCT RNFL
  6. Patient with media opacities that affect the reliability of OCT measurements , such as Cornea opacity, dense cataract with LOCS III of more than grade 2, vitreous haemorrhage
  7. Other optic neuropathy apart from glaucoma
  8. History of taking antioxidant supplement 3 months prior to recruitment.

Methods of Data Collection

This study will be conducted after obtaining ethical approval from the Universiti Sains Malaysia Ethical Committee (JPeM) and will be conducted in accordance to World Medical Association Declaration of Helsinki ethical principles for medical research involving human subjects.

Recruitment of Subject

Patient diagnosed with POAG and PACG attending Ophthalmology clinic, Hospital USM during study duration and fulfilled study inclusion and exclusion criteria. An informed and written consent will be taken and information form given to patients. The selected patients will be randomized into 2 groups (A and B) using sequentially numbered, opaque sealed envelopes (SNOSE). Group A patient will be consuming the chosen fruits and group B patient will not consume them.

Interventional Protocol

Patients in Group A will have to consume 2 types of fresh fruits per week as 2 servings once per day, daily for a 6-month duration. The chosen fruits are papaya, banana, mango and orange, and 2 types of fruits per week will be determined by the primary investigator. Size of the servings is according to the Malaysian Dietary Guideline 2020. They must eat them raw, and not to process or cook them in any other way. The fruits will be distributed by research assistant weekly throughout the study period. Patient will be reminded weekly using text messages or phone call by a research assistant for the fruit's consumption. Patients in group A and group B will be given a dietary diary throughout the study period, where the patient will mark the intake of fruits listed. The purpose of the diary is also to monitor patient intake of the fruits and daily diet as well.

IOP measurement

IOP measurement will be done using Goldmann Applanation Tonometer (GAT) in sitting position by the primary investigator (Nurul Munirah) who will be blinded. GAT will be calibrated daily before use to measure the IOP. Measurement of IOP will be done only at 8am - 10am (to prevent diurnal variation). Before IOP measurement, subjects are advised to avoid drinking coffee or any caffeinated drink 24 hours before and only to take light meal 2 hours before (to reduce the effect of hyperglycaemia and hydration on IOP). Only one eye will be measured, if both eyes are eligible, only right eye will be selected regardless of severity of glaucoma. Three readings of IOP will be measured and the mean reading will be taken as result. IOP measurement will be taken at baseline, first, third and sixth month post recruitment for group A and B.

OCT evaluation on RNFL thickness

Spectral domain Cirrus HD-OCT will be used to measure RNFL thickness and ONH parameters by a trained personnel who is blinded. Patient's eye will be dilated and patient will sit and rest his/her head on a support to keep it motionless in front of the OCT machine. The OCT will then scan patient's eye without touching it. Scans with signal strength less than 6, eye movement or blinking artifacts within the 1.73-mm radius around the ONH, or with segmentation errors will be repeated. If there is unsatisfactory measurement after 3 attempts, the patient will be excluded from the study. OCT will be conducted at baseline, first, third and sixth month post recruitment for group A and B.

Data Entry and Statistical Analysis

The data entry and analysis will be performed by using Statistical Package for the Social Sciences (SPSS) version 29 licensed to USM.

  • Paired T-test
  • Chi-square test
  • A one-way repeated measures analysis of variance (RM ANOVA)

Plans for minimizing study errors

These steps will be taken to minimize the errors while conducting the study:

  • The same instruments and equipment will be used for repeated measurement in this study.
  • The measurement of IOP will be done at the same time (8am-10am) in a day for all patients (to prevent diurnal variation).
  • OCT measurements will be performed by qualified and trained personnel only.
Being tested
Tropical fruits

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Tropical fruitsOther

    papaya, mango, banana, orange

Study groups in NCT06071494
Study groupRoleWhat they receive
Tropical FruitsExperimentalpatient will be consuming the chosen fruits, according to the size of the serving following Malaysian Dietary Guideline 2020
Receives: Other: Tropical fruits
Normal dietNo interventionpatient will consume normal diet as usual

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. intraocular pressure

    tonometer

    Measured: baseline, at 1 month , at 3 months and 6 months

  2. retinal nerve fibre layer

    Spectral domain Cirrus HD-OCT

    Measured: baseline, at 1 month , at 3 months and 6 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted6 Oct 2023
  2. Study start1 Feb 2024
  3. Primary completion1 Jan 2025
  4. Study completion1 May 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Investigator, Outcomes assessor
Enrolment
104 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06071494
Sponsor's protocol ID
RSCH ID-23-03744-7U6
Status last verified
Jul 2025
First submitted
1 Oct 2023
Last updated
17 Jul 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Weinreb RN, Khaw PT. Primary open-angle glaucoma. Lancet. 2004 May 22;363(9422):1711-20. doi: 10.1016/S0140-6736(04)16257-0.

    PubMed 15158634
  • Braakhuis A, Raman R, Vaghefi E. The Association between Dietary Intake of Antioxidants and Ocular Disease. Diseases. 2017 Jan 30;5(1):3. doi: 10.3390/diseases5010003.

    PubMed 28933356
  • Kang JH, Willett WC, Rosner BA, Buys E, Wiggs JL, Pasquale LR. Association of Dietary Nitrate Intake With Primary Open-Angle Glaucoma: A Prospective Analysis From the Nurses' Health Study and Health Professionals Follow-up Study. JAMA Ophthalmol. 2016 Mar;134(3):294-303. doi: 10.1001/jamaophthalmol.2015.5601.

    PubMed 26767881
  • Neufeld AH, Sawada A, Becker B. Inhibition of nitric-oxide synthase 2 by aminoguanidine provides neuroprotection of retinal ganglion cells in a rat model of chronic glaucoma. Proc Natl Acad Sci U S A. 1999 Aug 17;96(17):9944-8. doi: 10.1073/pnas.96.17.9944.

    PubMed 10449799

Questions about this trial

What is this clinical trial studying?

A study testing Tropical fruits in people with Primary Glaucoma, run by Universiti Sains Malaysia at 1 site in Malaysia.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 17 Jul 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Malaysia. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

intraocular pressure (time frame: baseline, at 1 month , at 3 months and 6 months). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06071494, which also lists 4 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 Jul 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in